Product Name

Celiprolol Hydrochloride

CAS Number

57470-78-7

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:
Celiprolol Hydrochloride
CAS Number:
57470-78-7
DrugBank:
DB04846
Formula:
C20-H33-N3-O4.Cl-H
Molecular Mass:
415.959
Synonyms:
3-(3-Acetil-4-(3-tert-butilamino-2-hidroxipropoxi)fenil)-1,1-dietilurea HCl, 3-(3-Acetil-4-(3-tert-butilamino-2-hidroxipropoxi)fenil)-1,1-dietilurea HCl [Spanish], 3-(3-Acetyl-4-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-1,1-diethylurea monohydrochloride, 3-(3-Acetyl-4-(3-tert-butylamino-2-hydroxypropoxy)phenyl)-1,1-diethylharnstoff HCl, 3-(3-Acetyl-4-(3-tert-butylamino-2-hydroxypropoxy)phenyl)-1,1-diethylharnstoff HCl [German], 3-(3-Acetyl-4-(3-tert-butylamino-2-hydroxypropoxy)phenyl)-1,1-diethylurea hydrochloride, CCRIS 1095, Celiprolol clorhidrato, Celiprolol clorhidrato [Spanish], Celiprolol HCl, Celiprolol hydrochlorid, Celiprolol hydrochlorid [German], Celiprolol hydrochloride, Clorhidrato de celiprolol, Clorhidrato de celiprolol [Spanish], EINECS 260-752-2, Selecor, Selectrol, St 1396, UNII-G1M3398594, Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-, monohydrochloride
SMILES:
c1(c(cc(NC(N(CC)CC)=O)cc1)C(C)=O)OC[C@@H](CNC(C)(C)C)O.Cl
InChi:
1S/C20H33N3O4.ClH/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6;/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26);1H
General Reference:
General Reference:

Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, Fauret AL, Fiessinger JN, Germain DP, Georgesco G, Hulot JS, De Paepe A, Plauchu H, Jeunemaitre X, Laurent S, Boutouyrie P: Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010 Oct 30;376(9751):1476-84. doi: 10.1016/S0140-6736(10)60960-9. Epub 2010 Sep 7. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210. 

Ask us about this product

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants
  • Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any submission type based on specific customer requirements

Find an API Product

Search
Generic filters